Jefferies Group's ABT Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 51,041 shares of Abbott Laboratories (ABT) worth $6.84 M, representing 0.03% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in ABT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 184,508 shares. Largest reduction occurred in Q2 2025, reducing 203,936 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Abbott Laboratories (ABT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Abbott Laboratories (ABT) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2022 | +262,018 | New Buy | 262,018 | $109.79 |
| Q1 2023 | +26,924 | Add 10.28% | 288,942 | $101.26 |
| Q2 2023 | -78,953 | Reduce 27.32% | 209,989 | $109.02 |
| Q3 2023 | -37,669 | Reduce 17.94% | 172,320 | $96.85 |
| Q4 2023 | -58,045 | Reduce 33.68% | 114,275 | $110.07 |
| Q1 2024 | +184,508 | Add 161.46% | 298,783 | $113.66 |
| Q2 2024 | -138,790 | Reduce 46.45% | 159,993 | $103.91 |
| Q3 2024 | -84,227 | Reduce 52.64% | 75,766 | $114.01 |
| Q4 2024 | +123,843 | Add 163.45% | 199,609 | $113.11 |
| Q1 2025 | +43,939 | Add 22.01% | 243,548 | $132.65 |
| Q2 2025 | -203,936 | Reduce 83.74% | 39,612 | $136.01 |
| Q3 2025 | +11,429 | Add 28.85% | 51,041 | $133.94 |
Jefferies Group's Abbott Laboratories Investment FAQs
Jefferies Group first purchased Abbott Laboratories (ABT) in Q4 2022, acquiring 262,018 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Abbott Laboratories (ABT) for 12 quarters since Q4 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to Abbott Laboratories (ABT) was in Q4 2022, adding 262,018 shares worth $28.77 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 51,041 shares of Abbott Laboratories (ABT), valued at approximately $6.84 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Abbott Laboratories (ABT) represents approximately 0.03% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in Abbott Laboratories (ABT) was 298,783 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.